about
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose ControlLiraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trialDivergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemiaA critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist.Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis.The importance of synthetic drugs for type 2 diabetes drug discovery.A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position.Incretins: their physiology and application in the treatment of diabetes mellitus.Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.Liraglutide for Type 2 diabetes and obesity: a 2015 update.Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast.Effects of the GLP-1 Receptor Agonist Dulaglutide on the Structure of the Exocrine Pancreas of Cynomolgus Monkeys.Incretin-based therapies: facing the realities of benefits versus side effects.
P2860
Q26750746-41E8A4EF-1281-4E75-8001-3904CFC32A2DQ28661700-CB95F739-4A99-4313-A0E7-0A1F4FC0E6E4Q34041974-CD36B22E-093F-4B16-8D2A-8F7760D47A0EQ36942123-DF9848C2-3D85-4153-BAAD-CE6FB12D7D78Q37428774-253DD6FA-0FB5-4CB6-9ED1-018E7C0E292BQ38101993-E82DDD1D-14AF-492C-B4C4-B4E3AEE2AEF7Q38139508-468B568D-39B6-4E74-B876-5E22AE31481FQ38202207-A62B476C-C3DF-4C7A-8C92-1CEA5B420485Q38225693-C096FA67-3DA9-483E-BE3C-EFEC5BCC9344Q38242089-1CC0491C-A01A-4524-B58B-00AC8ECDC571Q38536672-F8ED52A1-1B0C-4A98-9BCD-41C9FF108327Q39156623-4C8E7552-2AF7-436F-AE5F-93D5B053337BQ39213738-FF9C727D-FD07-4B95-8F75-30724475C4F3Q40852125-B7D064A2-2015-4568-BA72-924B9E8626D7Q42921290-B7225F0F-B71A-4B91-9A17-39A84609A427
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pancreatitis: a potential complication of liraglutide?
@en
type
label
Pancreatitis: a potential complication of liraglutide?
@en
prefLabel
Pancreatitis: a potential complication of liraglutide?
@en
P2093
P2860
P356
P1476
Pancreatitis: a potential complication of liraglutide?
@en
P2093
Andrea S Franks
Christa M George
Phillip H Lee
P2860
P304
P356
10.1345/APH.1Q789
P407
P577
2012-11-07T00:00:00Z